Best practices for balancing diagnosis, staging, and tissue for testing. Role of EBUS and biomarker testing. Cover success rates reported in literature for different biopsy modalities. Role of ROSE, cover special scenarios (effusions, bone metes, brain mets, etc.) Considerations for QNS results: ct-DNA, re-biopsy.
--
This non-CME education is brought to you by CHEST and sponsored by AstraZeneca.
Copyright for this content is held by the American College of Chest Physicians. Permission to redistribute is required.
